Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Baxter International (Vero cell technology)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Producer and provider of vaccines. The unit is an advanced, cell-based technology for vaccines production. It is used to produce vaccines including H5N1, H1N1 and seasonal influenza. It includes Baxter's production facility in Bohumil, Czech Republic.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Primary Office
  • Bohumil
  • Czech Republic

Baxter International (Vero cell technology) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Baxter International (Vero cell technology)‘s full profile, request access.

Request full access to PitchBook

Baxter International (Vero cell technology) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Baxter International (Vero cell technology)‘s full profile, request access.

Request full access to PitchBook